AbbVie: all 2,241 studies

Page 3 of 23. Open to participants first (134), then studies with results posted, then the rest; newest registration first within each.

• A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic MigraineCompletedNCT04437433Phase 3Results posted
• A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease SymptomsCompletedNCT04435600Phase 3Results posted
• A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease SymptomsCompletedNCT04430855Phase 2Results posted
• A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years OldCompletedNCT04414397Phase 3Results posted
• Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With PresbyopiaTerminatedNCT04403763Phase 1/2Results posted
• Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye DiseaseCompletedNCT04393441Phase 3Results posted
• Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's DiseaseCompletedNCT04380142Phase 3Results posted
• Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary InjuryCompletedNCT04375397Phase 2Results posted
• A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male ParticipantsCompletedNCT04320745Phase 4Results posted
• A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic StrokeCompletedNCT04309474Phase 2Results posted
• A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha ExpressionCompletedNCT04296890Phase 3Results posted
• A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT04285580Phase 3Results posted
• A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With HypogonadismCompletedNCT04274894Phase 4Results posted
• A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresCompletedNCT04244175Phase 2Results posted
• Flexible-Dose Trial in Early Parkinson's Disease (PD)CompletedNCT04223193Phase 3Results posted
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) ExpressionCompletedNCT04209855Phase 3Results posted
• A Study to Evaluate The Impact on Skin Quality Attributes by Juvederm® Volite Injection on Healthy VolunteersCompletedNCT04206293Not applicableResults posted
• Fixed-Dose Trial in Early Parkinson's Disease (PD)CompletedNCT04201093Phase 3Results posted
• Magnetic Muscle Stimulation of Abdominal MuscleTerminatedNCT04199312Not applicableResults posted
• Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT04195698Phase 3Results posted
• Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With MigraineCompletedNCT04179474Phase 1Results posted
• A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial SpondyloarthritisCompletedNCT04169373Phase 3Results posted
• Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-CCompletedNCT04166058Phase 3Results posted
• A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)TerminatedNCT04161885Phase 3Results posted
• CoolSculpting® the Upper Arms and Inner Thighs in Participants of Chinese Descent (XinCOOL)CompletedNCT04142450Not applicableResults posted
• A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid ParticipantsCompletedNCT04124705Phase 2Results posted
• Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional ConstipationCompletedNCT04110145Phase 2Results posted
• A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional ChemotherapyCompletedNCT04102020Phase 3Results posted
• A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or IxekizumabCompletedNCT04102007Phase 3Results posted
• AGN-151586 Dose-Ranging Study for Treatment of Glabellar LinesCompletedNCT04096326Phase 2Results posted
• BOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle ProminenceCompletedNCT04073303Phase 3Results posted
• A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)TerminatedNCT04064827Phase 3Results posted
• A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye DiseaseCompletedNCT04030962Phase 1/2Results posted
• Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)CompletedNCT04026113Phase 3Results posted
• EMS for Abdominal and Gluteal Muscle ToningCompletedNCT03983304Not applicableResults posted
• A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)CompletedNCT03978520Phase 2Results posted
• A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222CompletedNCT03969888Phase 2Results posted
• Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary SyndromeCompletedNCT03951077Phase 2Results posted
• A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive ChemotherapyCompletedNCT03941964Phase 3Results posted
• Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic MigraineCompletedNCT03939312Phase 3Results posted
• A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaCompletedNCT03926169Phase 2Results posted
• A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic FibrosisCompletedNCT03924947Phase 4Results posted
• A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety DisorderCompletedNCT03924323Phase 4Results posted
• BOTOX® for the Treatment of Platysma ProminenceCompletedNCT03915067Phase 2Results posted
• International CoolSculpting: Study to Evaluate Patient Satisfaction for Non-Invasive Fat Reduction in Abdomen and/or Flanks (iCOOL)CompletedNCT03909100Not applicableResults posted
• Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)CompletedNCT03889444Results posted
• A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCompletedNCT03886220Phase 4Results posted
• A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque PsoriasisCompletedNCT03875508Phase 3Results posted
• A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque PsoriasisCompletedNCT03875482Phase 3Results posted
• CoolSculpting and RF for the SubmentalCompletedNCT03873779Not applicableResults posted
• A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic LeukemiaCompletedNCT03873493Phase 2Results posted
• Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)CompletedNCT03868254Results posted
• BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle ProminenceCompletedNCT03861936Phase 2Results posted
• A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)TerminatedNCT03859869Phase 4Results posted
• A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With PresbyopiaCompletedNCT03857542Phase 3Results posted
• Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic MigraineCompletedNCT03855137Phase 3Results posted
• Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye DiseaseTerminatedNCT03827564Not applicableResults posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)CompletedNCT03823391Phase 2Results posted
• A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With UpadacitinibTerminatedNCT03823378Phase 2Results posted
• Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With PresbyopiaCompletedNCT03804268Phase 3Results posted
• A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip AugmentationCompletedNCT03796728Phase 4Results posted
• Diabetic Gastroparesis Study 05TerminatedNCT03786380Phase 3Results posted
• A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)CompletedNCT03781167Phase 3Results posted
• Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)CompletedNCT03779841Phase 2Results posted
• 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic MigraineCompletedNCT03777059Phase 3Results posted
• The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneCompletedNCT03739203Phase 3Results posted
• CoolSculpting and EMS for the AbdomenCompletedNCT03738891Not applicableResults posted
• A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT03738397Phase 3Results posted
• Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneCompletedNCT03738215Phase 3Results posted
• A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple SclerosisCompletedNCT03737851Phase 2Results posted
• A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple SclerosisCompletedNCT03737812Phase 2Results posted
• JUVÉDERM® VOLITE™ XC for Cheek Skin SmoothnessCompletedNCT03728309Not applicableResults posted
• A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell ArteritisCompletedNCT03725202Phase 3Results posted
• An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)TerminatedNCT03712787Phase 2Results posted
• A Study to Evaluate Participant Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial TreatmentCompletedNCT03712449Phase 4Results posted
• Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline DefinitionCompletedNCT03712137Phase 3Results posted
• A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic DermatitisCompletedNCT03706040Phase 2Results posted
• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic MigraineCompletedNCT03700320Phase 3Results posted
• A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)CompletedNCT03695237Phase 3Results posted
• A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior TherapyCompletedNCT03695185Phase 2Results posted
• A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid ArthritisCompletedNCT03682705Phase 2Results posted
• Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)TerminatedNCT03675776Phase 3Results posted
• A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) TherapyActive, not recruitingNCT03675308Phase 3Results posted
• A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)CompletedNCT03671148Phase 3Results posted
• Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)TerminatedNCT03668600Phase 3Results posted
• XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS)CompletedNCT03654885Phase 4Results posted
• A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT03653026Phase 3Results posted
• Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD)TerminatedNCT03614156Phase 3Results posted
• A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)CompletedNCT03607422Phase 3Results posted
• Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With SchizophreniaTerminatedNCT03593213Phase 3Results posted
• A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed FeaturesCompletedNCT03573297Phase 3Results posted
• Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive DisorderCompletedNCT03569475Phase 3Results posted
• Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)CompletedNCT03569293Phase 3Results posted
• A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic DermatitisActive, not recruitingNCT03568318Phase 3Results posted
• A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple MyelomaTerminatedNCT03567616Phase 2Results posted
• Study of Rapastinel as Monotherapy in Patients With MDDTerminatedNCT03560518Phase 3Results posted
• A Long-Term Study of Rovalpituzumab TesirineCompletedNCT03543358Phase 2Results posted
• A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)CompletedNCT03539549Phase 2Results posted
• Safety and Effectiveness of JUVÉDERM® VOLBELLA® With Lidocaine for Lip Enhancement in Chinese AdultsCompletedNCT03519204Not applicableResults posted
• A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal MenCompletedNCT03518034Phase 4Results posted

← AbbVie overview and focus areas